Externally applied medicament for treating rheumatoid arthritis and hyperosteogeny and preparation method thereof

Abstract

The invention relates to an externally applied medicament for treating rheumatoid arthritis and hyperosteogeny and a preparation method thereof. The externally applied medicament is prepared from the following raw materials: radix angelicae sinensis, safflower carthamus, ground beeltle, caulis spatholobi, myrrh, frankincense, large-leaved gentian, medicinal cyathula root, angelica dahurica, notopterygium root, radix sileris, drynaria rhizome, monkshood, radix aconiti agrestis, garden balsam stem, honeysuckle stem, common threewingnut root, ramulus mori, Dioscorea nipponica Makino, Rhizoma Homalomenae, cinnamon, cassia twig, baked ginger, radix stephaniae tetrandrae, rhizoma cibotii, caulis piperis kadsurae, lycopodium clavatum, radix clematidis, kudzuvine root, erycibe obtusifolia benth, loose knot, sangusis draconis, scorpion, centipede, pseudo-ginseng and honeysuckle. The preparation method comprises the following steps of: adding 3000ml water into the high quality traditional Chinese medicine raw materials, soaking for 2 hours, boiling with strong fire, decocting with slow fire for 1 hour, filtrating residues, concentrating the filtered liquid to 400ml, and subpackaging in a way of each bottle with 50ml, and sterilizing the decoction at a high temperature for later use. The traditional Chinese medicines are reasonably matched; and the medicament is direct in efficacy, low in cost, and convenient to use.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a medicine for external use for treating rheumatoid arthritis and hyperosteogeny and a preparation method thereof. Background technique [0002] The number of patients with rheumatoid arthritis and osteoporosis is increasing, and they are difficult to cure. They are regarded as one of the four chronic diseases by Western medicine. Once patients get sick, they will suffer from pain for life, cannot work and live normally, and suffer great physical and mental damage. At the same time, patients also need to take medication for a long time, which causes a great burden economically. At present, from the statistics of various regions, these two diseases are widely distributed and large in number, and both men, women and children are likely to suffer from this disease. [0003] Over the years, the medical field has carried out in-depth research on rheumatoid arthr...

AI Technical Summary

Problems solved by technology

[0003] For many years, the medical field has carried out in-depth research on rheumatoid arthritis and hyperosteogeny, but there are not many effective treatment methods at present. Most of the western medicine treatments can only provide temporary relief, cannot control the development of the disease, and are even more difficult to eradicate. Patients rely on hormones to relieve symptoms, which can only relieve temporary pain, and long-term use has relatively large side effects

Some methods of treating rheumatoid arthritis and hyperosteogeny by oral administration of traditional Chinese medicines have been published, but the effects are not obvious enough, and the effect is relatively slow. Long-term use has large side effects, high cost, and is difficult to persist.